19-55578993-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152600.3(ZNF579):c.647G>A(p.Arg216Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000329 in 1,533,096 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152600.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF579 | NM_152600.3 | c.647G>A | p.Arg216Gln | missense_variant | 2/2 | ENST00000325421.7 | NP_689813.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF579 | ENST00000325421.7 | c.647G>A | p.Arg216Gln | missense_variant | 2/2 | 2 | NM_152600.3 | ENSP00000320188 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000289 AC: 44AN: 152232Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000229 AC: 30AN: 131174Hom.: 0 AF XY: 0.000262 AC XY: 19AN XY: 72606
GnomAD4 exome AF: 0.000333 AC: 460AN: 1380864Hom.: 0 Cov.: 35 AF XY: 0.000298 AC XY: 203AN XY: 681680
GnomAD4 genome AF: 0.000289 AC: 44AN: 152232Hom.: 0 Cov.: 33 AF XY: 0.000269 AC XY: 20AN XY: 74382
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 12, 2024 | The c.647G>A (p.R216Q) alteration is located in exon 2 (coding exon 1) of the ZNF579 gene. This alteration results from a G to A substitution at nucleotide position 647, causing the arginine (R) at amino acid position 216 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at